Belvedere Trading Reduces $701K in Inhibrx Biosciences, Inc. ($INBX)
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Belvedere Trading reduced its position in Inhibrx Biosciences, Inc. ($INBX), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 0 shares of Inhibrx Biosciences, Inc. after selling 7,402 shares during the quarter.
Inhibrx Biosciences, Inc. Stock Down 23.2%
Shares of Inhibrx Biosciences, Inc. ($INBX) traded around $94.75 on Saturday, down 23.2% for the day.
Inhibrx Biosciences, Inc. Earnings
Analysts Set New Price Targets
About Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, which is in phase 1, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head non-small cell lung cancer cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
Get Inhibrx Biosciences, Inc. alerts
New 13F filings, insider trades, and analyst moves on $INBX, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.